NL-OMON25255
Other
Not Applicable
A randomized, placebo-controlled, double blind trial to study the effects of vitamin K2 and arterial calcification in patients with type 2 diabetes
MC Utrecht0 sites0 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Vitamin K, menaquinone-7, arterial calcification, dp-ucMGP, diabetes patiënts, arterial stiffness, bone metabolism.
- Sponsor
- MC Utrecht
- Status
- Other
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Middle aged men and women ¡Ý 40 years.
- •\- Diagnosed with type 2 diabetes.
Exclusion Criteria
- •\- Contra\-indication for undergoing 18F\-NaF PET/CT scan (pregnancy, breastfeeding, recent radiotherapy or chemotherapy).
- •\- Subject underwent amputation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A randomized, placebo-controlled, double blind trial to study the effects of Etidronate on ectopic CALCIfication in FAhr*s Disease or syndrome.Fahr's diseaseprimary familial brain calcification10007963NL-OMON53560niversitair Medisch Centrum Utrecht98
Completed
Phase 2
A randomized, placebo-controlled, double blind trial to investigate whether vitamin K2 can influence ongoing calcium deposition in patients with type 2 diabetesArterial calcificationcardiovascular disease10003216NL-OMON45148niversitair Medisch Centrum Utrecht70
Active, not recruiting
Phase 1
A study to investigate the efficacy and tolerability of the drug ESO-101 in adult patients with inflammation of the esophagusActive eosinophilic esophagitisMedDRA version: 20.1Level: PTClassification code 10064212Term: Eosinophilic oesophagitisSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2020-000082-16-PLEsoCap AG42
Active, not recruiting
Phase 4
Can treatment with Cerebrolysin improve recovery after acute ischemic stroke?Radiologically confirmed acute ischemic stroke with onset within 72 hours prior to screeningCirculatory SystemAcute ischemic strokeISRCTN88122184The foundation for the study of neuroscience and neuroregeneration290
Active, not recruiting
Phase 1
A study to investigate the efficacy and tolerability of the drug ESO-101 in adult patients with inflammation of the esophagusActive eosinophilic esophagitisMedDRA version: 20.1Level: PTClassification code 10064212Term: Eosinophilic oesophagitisSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2020-000082-16-NLEsoCap AG42